LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Excited-state dynamics of Wurster's salts.

    Grilj, Jakob / Buchgraber, Philipp / Vauthey, Eric

    The journal of physical chemistry. A

    2012  Volume 116, Issue 28, Page(s) 7516–7522

    Abstract: The excited-state dynamics of a series of Wurster's salts (p-phenylenediamine radical cations) with different subtituents on the nitrogen atoms was investigated under a variety of experimental conditions using a combination of ultrafast spectroscopic ... ...

    Abstract The excited-state dynamics of a series of Wurster's salts (p-phenylenediamine radical cations) with different subtituents on the nitrogen atoms was investigated under a variety of experimental conditions using a combination of ultrafast spectroscopic techniques. At room temperature, the lifetime of the lowest excited state of all radical cations is on the order of 200 fs, independently of the solvent, that is, water, nitriles, alcohols, and room-temperature ionic liquid. On the other hand, all cations, except that with the bulky nitrogen substituents, become fluorescent below 120 K. The observed dynamics can be accounted for by the presence of a conical intersection between the D(1) and D(0) states. For the cations with a small nitrogen substituent, this conical intersection could be accessed through a twist of one amino group, as already suggested for Wurster's Blue. However, this coordinate cannot be invoked for the cation with bulky nitrogen subtituents, and more probably, pyramidalization of the nitrogen center and/or deformation of the phenyl ring play an important role. Consequently, the excited-state dynamics of these structurally very similar Wurster's salts involves different decay mechanisms.
    MeSH term(s) Free Radicals/chemistry ; Molecular Structure ; Phenylenediamines/chemistry ; Quantum Theory ; Salts/chemistry
    Chemical Substances Free Radicals ; Phenylenediamines ; Salts ; 4-phenylenediamine (U770QIT64J)
    Language English
    Publishing date 2012-07-19
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1520-5215
    ISSN (online) 1520-5215
    DOI 10.1021/jp3045548
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: New Generation of sGC Stimulators: Discovery of Imidazo[1,2-

    Vakalopoulos, Alexandros / Wunder, Frank / Hartung, Ingo V / Redlich, Gorden / Jautelat, Rolf / Buchgraber, Philipp / Hassfeld, Jorma / Gromov, Alexey V / Lindner, Niels / Bierer, Donald / Gries, Jörg / Kroh, Walter / Paulsen, Holger / Mittendorf, Joachim / Lang, Dieter / Becker-Pelster, Eva / Brockschnieder, Damian / Geiss, Volker / Li, Volkhart /
    Straub, Alexander / Knorr, Andreas / Mondritzki, Thomas / Trübel, Hubert / Raschke, Marian / Schaefer, Martina / Thomas, Dirk / Sandner, Peter / Stasch, Johannes-Peter / Follmann, Markus

    Journal of medicinal chemistry

    2023  Volume 66, Issue 11, Page(s) 7280–7303

    Abstract: Herein, we describe the identification, chemical optimization, and preclinical characterization of novel soluble guanylate cyclase (sGC) stimulators. Given the very broad therapeutic opportunities for sGC stimulators, new tailored molecules for distinct ... ...

    Abstract Herein, we describe the identification, chemical optimization, and preclinical characterization of novel soluble guanylate cyclase (sGC) stimulators. Given the very broad therapeutic opportunities for sGC stimulators, new tailored molecules for distinct indications with specific pharmacokinetics, tissue distribution, and physicochemical properties will be required in the future. Here, we report the ultrahigh-throughput (uHTS)-based discovery of a new class of sGC stimulators from an imidazo[1,2-
    MeSH term(s) Humans ; Soluble Guanylyl Cyclase/metabolism ; Guanylate Cyclase/metabolism ; Hypertension/drug therapy ; Vasodilator Agents ; Pyridines/pharmacology ; Pyridines/therapeutic use ; Nitric Oxide/metabolism
    Chemical Substances Soluble Guanylyl Cyclase (EC 4.6.1.2) ; Guanylate Cyclase (EC 4.6.1.2) ; 2-(2-Chloro-4-(methylsulfonyl)-3-((2,2,2-trifluoroethoxy)methyl)benzoyl)-1,3-cyclohexanedione (BAY 747) ; Vasodilator Agents ; Pyridines ; Nitric Oxide (31C4KY9ESH)
    Language English
    Publishing date 2023-04-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.2c02082
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling.

    Graham, Keith / Lienau, Philip / Bader, Benjamin / Prechtl, Stefan / Naujoks, Jan / Lesche, Ralf / Weiske, Joerg / Kuehnlenz, Julia / Brzezinka, Krzysztof / Potze, Lisette / Zanconato, Francesca / Nicke, Barbara / Montebaur, Anna / Bone, Wilhelm / Golfier, Sven / Kaulfuss, Stefan / Kopitz, Charlotte / Pilari, Sabine / Steuber, Holger /
    Hayat, Sikander / Kamburov, Atanas / Steffen, Andreas / Schlicker, Andreas / Buchgraber, Philipp / Braeuer, Nico / Font, Nuria Aiguabella / Heinrich, Tobias / Kuhnke, Lara / Nowak-Reppel, Katrin / Stresemann, Carlo / Steigemann, Patrick / Walter, Annette O / Blotta, Simona / Ocker, Matthias / Lakner, Ashley / von Nussbaum, Franz / Mumberg, Dominik / Eis, Knut / Piccolo, Stefano / Lange, Martin

    Cell chemical biology

    2024  

    Abstract: This study describes the identification and target deconvolution of small molecule inhibitors of oncogenic Yes-associated protein (YAP1)/TAZ activity with potent anti-tumor activity in vivo. A high-throughput screen (HTS) of 3.8 million compounds was ... ...

    Abstract This study describes the identification and target deconvolution of small molecule inhibitors of oncogenic Yes-associated protein (YAP1)/TAZ activity with potent anti-tumor activity in vivo. A high-throughput screen (HTS) of 3.8 million compounds was conducted using a cellular YAP1/TAZ reporter assay. Target deconvolution studies identified the geranylgeranyltransferase-I (GGTase-I) complex as the direct target of YAP1/TAZ pathway inhibitors. The small molecule inhibitors block the activation of Rho-GTPases, leading to subsequent inactivation of YAP1/TAZ and inhibition of cancer cell proliferation in vitro. Multi-parameter optimization resulted in BAY-593, an in vivo probe with favorable PK properties, which demonstrated anti-tumor activity and blockade of YAP1/TAZ signaling in vivo.
    Language English
    Publishing date 2024-03-19
    Publishing country United States
    Document type Journal Article
    ISSN 2451-9448
    ISSN (online) 2451-9448
    DOI 10.1016/j.chembiol.2024.02.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies.

    Berger, Markus / Wortmann, Lars / Buchgraber, Philipp / Lücking, Ulrich / Zitzmann-Kolbe, Sabine / Wengner, Antje M / Bader, Benjamin / Bömer, Ulf / Briem, Hans / Eis, Knut / Rehwinkel, Hartmut / Bartels, Florian / Moosmayer, Dieter / Eberspächer, Uwe / Lienau, Philip / Hammer, Stefanie / Schatz, Christoph A / Wang, Qiuwen / Wang, Qi /
    Mumberg, Dominik / Nising, Carl F / Siemeister, Gerhard

    Journal of medicinal chemistry

    2021  Volume 64, Issue 17, Page(s) 12723–12737

    Abstract: Eukaryotes have evolved two major pathways to repair potentially lethal DNA double-strand breaks. Homologous recombination represents a precise, DNA-template-based mechanism available during the S and G2 cell cycle phase, whereas non-homologous end ... ...

    Abstract Eukaryotes have evolved two major pathways to repair potentially lethal DNA double-strand breaks. Homologous recombination represents a precise, DNA-template-based mechanism available during the S and G2 cell cycle phase, whereas non-homologous end joining, which requires DNA-dependent protein kinase (DNA-PK), allows for fast, cell cycle-independent but less accurate DNA repair. Here, we report the discovery of
    MeSH term(s) Animals ; Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/pharmacology ; Cell Line, Tumor ; Cell Proliferation ; DNA-Activated Protein Kinase/genetics ; DNA-Activated Protein Kinase/metabolism ; Drug Synergism ; Drug Therapy, Combination ; Gene Expression Regulation/drug effects ; Hepatocytes/drug effects ; Humans ; Mice ; Molecular Structure ; Phosphatidylinositol 3-Kinases/genetics ; Rats ; Structure-Activity Relationship ; TOR Serine-Threonine Kinases/genetics ; TOR Serine-Threonine Kinases/metabolism ; Xenograft Model Antitumor Assays
    Chemical Substances Antineoplastic Agents ; MTOR protein, human (EC 2.7.1.1) ; DNA-Activated Protein Kinase (EC 2.7.11.1) ; PRKDC protein, human (EC 2.7.11.1) ; TOR Serine-Threonine Kinases (EC 2.7.11.1)
    Language English
    Publishing date 2021-08-24
    Publishing country United States
    Document type Journal Article
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.1c00762
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Total synthesis of berkelic acid.

    Snaddon, Thomas N / Buchgraber, Philipp / Schulthoff, Saskia / Wirtz, Conny / Mynott, Richard / Fürstner, Alois

    Chemistry (Weinheim an der Bergstrasse, Germany)

    2010  Volume 16, Issue 40, Page(s) 12133–12140

    Abstract: A productive total synthesis of both enantiomers of berkelic acid (1) is outlined that takes the structure revision of this bioactive fungal metabolite previously proposed by our group into account. The successful route relies on a fully optimized triple- ...

    Abstract A productive total synthesis of both enantiomers of berkelic acid (1) is outlined that takes the structure revision of this bioactive fungal metabolite previously proposed by our group into account. The successful route relies on a fully optimized triple-deprotection/1,4-addition/spiroacetalization cascade reaction sequence, which delivers the tetracyclic core 32 of the target as a single isomer in excellent yield. The required cyclization precursor 31 is assembled from the polysubstituted benzaldehyde derivative 20 and methyl ketone 25 by an aldol condensation, in which the acetyl residue in 20 transforms from a passive protecting group into an active participant. Access to fragment 25 takes advantage of the Collum-Godenschwager variant of the ester enolate Claisen rearrangement, which clearly surpasses the classical Ireland-Claisen procedure in terms of diastereoselectivity. Although it is possible to elaborate 32 into the target without any additional manipulations of protecting groups, a short detour consisting in the conversion of the phenolic -OH into the corresponding TBS-ether is beneficial. It tempers the sensitivity of the compound toward oxidation and hence improves the efficiency and reliability of the final stages. Orthogonal ester groups for the benzoate and the aliphatic carboxylate terminus of the side chain secure an efficient liberation of free berkelic acid in the final step of the route.
    MeSH term(s) Cyclization ; Molecular Structure ; Oxidation-Reduction ; Spiro Compounds/chemical synthesis ; Spiro Compounds/chemistry ; Stereoisomerism
    Chemical Substances Spiro Compounds ; berkelic acid
    Language English
    Publishing date 2010-10-25
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1478547-x
    ISSN 1521-3765 ; 0947-6539
    ISSN (online) 1521-3765
    ISSN 0947-6539
    DOI 10.1002/chem.201001133
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: A Synthesis-Driven Structure Revision of Berkelic Acid Methyl Ester

    Buchgraber, Philipp / Snaddon, Thomas N / Wirtz, Conny / Mynott, Richard / Goddard, Richard / Fürstner, Alois

    Angewandte Chemie. 2008 Oct. 20, v. 47, no. 44

    2008  

    Language English
    Dates of publication 2008-1020
    Size p. 8450-8454.
    Publishing place Wiley-VCH Verlag
    Document type Article
    ZDB-ID 2011836-3
    ISSN 1521-3773 ; 1433-7851
    ISSN (online) 1521-3773
    ISSN 1433-7851
    DOI 10.1002/anie.200803339
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article ; Online: A synthesis-driven structure revision of berkelic acid methyl ester.

    Buchgraber, Philipp / Snaddon, Thomas N / Wirtz, Conny / Mynott, Richard / Goddard, Richard / Fürstner, Alois

    Angewandte Chemie (International ed. in English)

    2008  Volume 47, Issue 44, Page(s) 8450–8454

    MeSH term(s) Enzyme Inhibitors/chemical synthesis ; Enzyme Inhibitors/chemistry ; Enzyme Inhibitors/pharmacology ; Esters/chemical synthesis ; Esters/chemistry ; Esters/pharmacology ; Magnetic Resonance Spectroscopy ; Matrix Metalloproteinase Inhibitors ; Spiro Compounds/chemical synthesis ; Spiro Compounds/chemistry ; Spiro Compounds/pharmacology ; Stereoisomerism ; Structure-Activity Relationship
    Chemical Substances Enzyme Inhibitors ; Esters ; Matrix Metalloproteinase Inhibitors ; Spiro Compounds ; berkelic acid
    Language English
    Publishing date 2008
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2011836-3
    ISSN 1521-3773 ; 1433-7851
    ISSN (online) 1521-3773
    ISSN 1433-7851
    DOI 10.1002/anie.200803339
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top